• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

惊恐障碍长期药物治疗研究的入组预测因素。

Predictors of entering a long-term drug treatment study of panic disorder.

作者信息

Mavissakalian Matig R, Guo Shenyang

机构信息

Department of Psychiatry, Case Western Reserve University and The Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, Ohio, USA.

出版信息

Compr Psychiatry. 2002 Mar-Apr;43(2):88-94. doi: 10.1053/comp.2002.30803.

DOI:10.1053/comp.2002.30803
PMID:11893985
Abstract

Three hundred thirty-three consecutive individuals with panic and agoraphobic-like symptoms were evaluated as part of the screening for entry in a long-term imipramine treatment study of panic disorder with agoraphobia. The present report compares three subgroups of potential subjects--those who entered the study (n = 139, 41.7%), those who were rejected from participation based on exclusion criteria (n = 161, 48.3%), and those who qualified to enter but refused participation (n = 33, 10.0%)-in order to characterize pretreatment attrition and address two specific questions: What variables other than inclusion and exclusion criteria predict the likelihood of entering the trial?, and What variables significantly predict the likelihood of refusal to participate? Logistic regression analysis revealed that the likelihood of entering the trial was influenced significantly and independently by a number of variables that included extroversion, anxiety, and work satisfaction and performance measures. The refused and rejected groups differed significantly on a number of variables that were not a priori exclusionary criteria, such as a history of substance abuse other than alcohol and current use of alcohol to decrease anxiety, but none of these variables emerged as independent, significant predictors of refusing behavior as a separate category of nonparticipation. Findings suggest the presence of factors common to both the rejected and the refused groups that significantly influence pretreatment attrition and caution that categorizing pretreatment attrition into refused and rejected categories may not always be clear cut. Research and clinical implications are briefly discussed.

摘要

333名有惊恐和广场恐怖症样症状的连续个体作为进入一项关于伴有广场恐怖症的惊恐障碍的长期丙咪嗪治疗研究的筛选的一部分接受了评估。本报告比较了潜在受试者的三个亚组——进入研究的受试者(n = 139,41.7%)、基于排除标准被拒绝参与的受试者(n = 161,48.3%)以及符合进入条件但拒绝参与的受试者(n = 33,10.0%)——以便描述治疗前损耗情况并回答两个具体问题:除了纳入和排除标准外,哪些变量可预测进入试验的可能性?以及哪些变量能显著预测拒绝参与的可能性?逻辑回归分析显示,进入试验的可能性受到包括外向性、焦虑以及工作满意度和绩效指标等多个变量的显著且独立的影响。拒绝参与组和被拒绝组在一些并非先验排除标准的变量上存在显著差异,比如除酒精外的物质滥用史以及当前使用酒精来减轻焦虑,但这些变量均未成为作为非参与的一个单独类别的拒绝行为的独立、显著预测因素。研究结果表明,被拒绝组和拒绝参与组存在共同因素,这些因素显著影响治疗前损耗,并警示将治疗前损耗分为拒绝参与和被拒绝两类可能并不总是清晰明确的。本文简要讨论了研究和临床意义。

相似文献

1
Predictors of entering a long-term drug treatment study of panic disorder.惊恐障碍长期药物治疗研究的入组预测因素。
Compr Psychiatry. 2002 Mar-Apr;43(2):88-94. doi: 10.1053/comp.2002.30803.
2
Predictors of outcome in panic disorder: a 5-year prospective follow-up study.惊恐障碍预后的预测因素:一项为期5年的前瞻性随访研究。
J Affect Disord. 1996 Nov 25;41(2):111-6. doi: 10.1016/s0165-0327(96)00077-8.
3
Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.惊恐障碍伴广场恐惧症患者丙咪嗪治疗的长期维持与停药
Arch Gen Psychiatry. 1999 Sep;56(9):821-7. doi: 10.1001/archpsyc.56.9.821.
4
Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.伴有广场恐惧症的惊恐障碍的治疗:四种心理社会治疗联合丙咪嗪或安慰剂的随机安慰剂对照试验。
Cogn Behav Ther. 2008;37(3):146-59. doi: 10.1080/16506070701743120.
5
Physical, mental, and social catastrophic cognitions as prognostic factors in cognitive-behavioral and pharmacological treatments for panic disorder.身体、心理和社会层面的灾难性认知作为惊恐障碍认知行为治疗和药物治疗中的预后因素。
J Consult Clin Psychol. 2005 Jun;73(3):506-14. doi: 10.1037/0022-006X.73.3.506.
6
Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
Biol Psychiatry. 1998 Jun 1;43(11):848-54. doi: 10.1016/s0006-3223(97)00376-4.
7
The use of the Panic and Agoraphobia Scale in a clinical trial.惊恐与广场恐怖症量表在一项临床试验中的应用。
Psychiatry Res. 1998 Jan 16;77(1):43-9. doi: 10.1016/s0165-1781(97)00118-2.
8
Preliminary evidence for cognitive mediation during cognitive-behavioral therapy of panic disorder.惊恐障碍认知行为疗法中认知调节的初步证据。
J Consult Clin Psychol. 2007 Jun;75(3):374-9. doi: 10.1037/0022-006X.75.3.374.
9
Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.认知行为疗法、丙咪嗪或两者联合治疗惊恐障碍:一项随机对照试验。
JAMA. 2000 May 17;283(19):2529-36. doi: 10.1001/jama.283.19.2529.
10
A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.一项双盲安慰剂对照试验,比较氟伏沙明和丙咪嗪治疗伴或不伴广场恐怖症的惊恐障碍的效果。
Psychopharmacol Bull. 1996;32(1):135-41.

引用本文的文献

1
A trans-diagnostic review of anxiety disorder comorbidity and the impact of multiple exclusion criteria on studying clinical outcomes in anxiety disorders.焦虑症共病的跨诊断综述以及多重排除标准对焦虑症临床结局研究的影响。
Transl Psychiatry. 2016 Jun 28;6(6):e847. doi: 10.1038/tp.2016.108.
2
Generalizability of pharmacological and psychotherapy clinical trial results for borderline personality disorder to community samples.边缘型人格障碍药物治疗和心理治疗临床试验结果对社区样本的可推广性。
Personal Disord. 2015 Jan;6(1):81-7. doi: 10.1037/per0000091.
3
Prevalence of subthreshold hypomania and impact on internal validity of RCTs for major depressive disorder: results from a national epidemiological sample.
阈下轻躁狂的患病率及其对重性抑郁障碍 RCT 内部有效性的影响:来自全国流行病学样本的结果。
PLoS One. 2013;8(2):e55448. doi: 10.1371/journal.pone.0055448. Epub 2013 Feb 6.
4
Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research.受试者资格标准会极大地影响酒精治疗效果研究的结果。
J Stud Alcohol Drugs. 2008 Sep;69(5):757-64. doi: 10.15288/jsad.2008.69.757.
5
Panic disorder, alcohol and substance abuse, and benzodiazepine prescription.惊恐障碍、酒精和物质滥用以及苯二氮䓬类药物处方。
Prim Care Companion J Clin Psychiatry. 2005;7(5):246-8. doi: 10.4088/pcc.v07n0510b.